Pinealon
Overview
Research-use synthetic tripeptide supplied for studies of neuronal signaling, oxidative-stress response, and brain-aging pathway models.
- Concentration
- 20 mg
- Stock
- In stock
Product details
Pinealon is a synthetic Glu-Asp-Arg tripeptide used in research models of neuronal signaling and oxidative-stress response. Pattern lists this material for controlled laboratory research.
Research Targets: Neuronal gene-expression pathways, mitochondrial stress response, oxidative-stress signaling, synaptic plasticity models.
Key Feature: Short bioregulatory tripeptide format for neural pathway research.
Research Focus Areas: Neuronal differentiation models, brain-aging pathway studies, cognitive signaling research, oxidative-stress response.
Common Models: Neuronal cultures, oxidative-stress paradigms, brain tissue model systems.
Mechanistic Interests: Mitochondrial enzyme markers, neuronal gene expression, synaptic pathway signaling, redox-response pathways.
Use Boundary: Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Product documentation
Certificate of Analysis
Pinealon
Review the public certificate available for this product before creating an account or checking out.
Research context
Peptide guide
Open full guide- Guide profile
- EDR Peptide Bioregulator
- Composition
- Synthetic tripeptide bioregulator composed of glutamic acid, aspartic acid, and arginine (Glu-Asp-Arg sequence)
- Discovery
- Developed in Russia as part of investigations into short peptides derived from brain and pineal gland extracts (e.g., related to Cortexin polypeptide complexes)
- Research scope
- Most data come from preclinical studies (in vitro cell cultures, rodent models) and limited human observations or small-scale applications
- Regulatory status
- No large-scale randomized clinical trials exist; remains investigational
Safety context
- Limited information; caution advised in neurological conditions without oversight
- Lacks major regulatory approval for medical use
- Evidence predominantly from animal/in vitro studies with very limited human validation
Research-use notice: Pinealon is a short-peptide bioregulator with preclinical literature for neuronal stress, cognition-related signaling, and aging-associated brain models. Evidence is predominantly animal or in vitro, with very limited human validation, and it lacks major regulatory approval for medical use. Clinical decisions require qualified medical oversight.
Full guide includes 10 reference entries.
One kit adds 10 vials to checkout.